A A A Text Size
E-mail E-mail This Page
 
Faculty Summaries
Warren D Kruger, PhD
Warren D Kruger, PhD
Professor
  • Adjunct Professor, Temple University School of Medicine, Dept. of Pharmacology
  • Adjunct Professor, Department of Biochemistry and Molecular Biology, Drexel University College of Medicine
Warren.Kruger@fccc.edu
Office Phone: 215-728-3030
Fax: 215-214-1623
Office: P3001B
Lab: P3016
Genetic Defects in Methionine Metabolism and Cancer

Methionine is an essential amino acid that is a key ingredient for the construction of proteins and other important biological molecules (Figure: Methionine Metabolic Pathway). The overall interest of my laboratory is how alterations in the methionine metabolic pathways contribute to human disease. Mutations and polymorphisms in methionine metabolic genes have been implicated in a variety of human diseases, ranging from rare inborn errors of metabolism to common diseases such as cardiovascular disease and cancer. Currently there are three major projects in the lab. Two concern particular methionine metabolic genes, cystathionine beta-synthase (CBS) and methylthioadenosine phosphorylase (MTAP). The third project is new and involves using methionine restriction in combination with COX-2 inhibitors for chemoprevention of breast cancer.

Description of research projects
Selected Publications
  1. Gupta S, Kühnisch J, Mustafa A, Lhotak S, Schlacterman A, Slifker MJ, Klein-Szanto AJ, High KA, Austin RC, Kruger WD. Mouse models of cystathionine β-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J. 2009 Mar;23(3):883-93. PubMed
  2. Singh LR, Kruger WD. Functional rescue of mutant human cystathionine β synthase by manipulation of Hsp26 and Hsp70 levels in Saccharomyces cerevisiae. J Biol Chem. 2009;284:4238-45. PubMed
  3. Mustafa A, Kruger WD. Suppression of tumor formation by a cyclooxygenase-2 inhibitor and a peroxisome proliferator-activated receptor γ agonist in an in vivo mouse model of spontaneous breast cancer. Clin Cancer Res. 2008;14:4935-42. PubMed
  4. Singh LR, Gupta S, Honig N, Kraus JP, Kruger WD. Activation of mutant enzyme function by proteasome inhibitors and treatments that induce Hsp70. PLOS Genetics Jan;6(1):e1000807, 2010.
  5. Kadariya Y, Yin B, Tang BQ, Shinton SA, Quinlivan EP, Hua X, Klein-Szanto A, Al-Saleem TI, Bassing CH, Hardy RR, Kruger WD. Mice Heterozygous for Germ-line Mutations in Methylthioadenosine Phosphorylase (MTAP) Die Prematurely of T-Cell Lymphoma. Cancer Res. 2009 Jul;69(14):5961-9.
All publications